Explore the words cloud of the oncNGS project. It provides you a very rough idea of what is the project "oncNGS" about.
The following table provides information about the project.
|Coordinator Country||Belgium [BE]|
|Total cost||12˙221˙843 €|
|EC max contribution||10˙999˙659 € (90%)|
1. H2020-EU.3.1.5. (Methods and data)
|Duration (year-month-day)||from 2020-01-01 to 2024-12-31|
Take a look of project's partnership.
|2||ALLEANZA CONTRO IL CANCRO||IT (ROMA)||participant||434˙614.00|
|3||INSTITUT CATALA D'ONCOLOGIA||ES (L'HOSPITALET DEL LLOBREGAT)||participant||314˙317.00|
|4||HOSPICES CIVILS DE LYON||FR (LYON)||participant||300˙375.00|
|5||INSTITUT JULES BORDET||BE (BRUXELLES)||participant||300˙375.00|
|6||INSTITUT CURIE||FR (PARIS)||participant||300˙111.00|
|7||LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN||DE (MUENCHEN)||participant||252˙000.00|
|8||AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA||ES (BARCELONA)||participant||189˙247.00|
|9||DE CLERCQ & PARTNERS||BE (SINT-MARTENS-LATEM)||participant||189˙225.00|
|10||CHARITE - UNIVERSITAETSMEDIZIN BERLIN||DE (BERLIN)||participant||89˙367.00|
|11||FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON||ES (BARCELONA)||participant||48˙312.00|
|12||FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON||ES (SORIA)||participant||48˙296.00|
|13||INSTITUT NATIONAL DU CANCER GIP||FR (BOULOGNE BILLANCOURT)||participant||48˙296.00|
|14||STICHTING KANKERREGISTER - FONDATION REGISTRE DU CANCER||BE (Brussels)||participant||48˙296.00|
oncNGS consortium challenges the market to research and develop novel affordable solutions to provide the best NGS tests, for all solid tumours / lymphomas patients. The challenge will consist in providing: (1) efficient molecular DNA/RNA profiling of tumour-derived material in liquid biopsies by means of (2) pan-cancer tumour marker analysis kit including NGS analysis integrated with (3) an ICT decision support system including analytical test interpretation and reporting. Thanks to the provided solutions, oncNGS consortium will be able to address their common identified unmet medical needs: (1) Establishment of valuable common tumour profiling strategy allowing to provide equal access to innovative medicines to all; (2) Outcome research analysis after treatments with targeted therapies as diverse testing leads to lowering the pooling capacity of obtained results, needed to obtain large enough sample numbers to perform statistics analyses; (3) Application of such essential testing to all patients, breaking down current unacceptable inequities due to the high costs of current diagnostics tests. oncNGS is a strong consortium composed by eight buyers from five member states (SC and IJB from Belgium, IC and HCL from France, HC and LMU from Germany, ACC from Italy and ICO from Spain) supported by six entities with wide experience in their fields (AQuAS from Spain is expert in precommercial procurement, BCR from Belgium and INCa from France are experts in cancer control, IBSAL and VHIO are experienced in biomedical research in the field of haematologic malignancies and DCP is experts in intellectual property rights and freedom to operate analysis) oncNGS consortium will challenge the market launching a pre-commercial procurement procedure, a competitive process enabling the buyers to compare the developments carried out by the contracted suppliers through three phases: solution design, prototyping and clinical validation of a limited set of R&D supplies.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ONCNGS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ONCNGS" are provided by the European Opendata Portal: CORDIS opendata.
Integrated and standardized NGS workflows for Personalised therapyRead More
A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized healthRead More
EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.Read More